Author: admin

  • LyondellBasell (LYB) Losses Deepen 24.8% Annually, Challenging Recovery Narrative Despite Profit Turnaround Forecast

    LyondellBasell (LYB) Losses Deepen 24.8% Annually, Challenging Recovery Narrative Despite Profit Turnaround Forecast

    LyondellBasell Industries (LYB) reported widening losses, with annual losses increasing by 24.8% per year over the past five years. Available forecasts expect revenue to decline 7.1% each year for the next three years, even as analysts see annual earnings rebounding at a pace of 52.66%, with a return to profitability anticipated in the same period.

    See our full analysis for LyondellBasell Industries.

    Next, we’ll see how these headline results compare with the prevailing narratives and expectations around LYB. Some views may be confirmed, while others might get a reality check.

    See what the community is saying about LyondellBasell Industries

    NYSE:LYB Earnings & Revenue History as at Nov 2025
    • Analyst projections show profit margins improving from just 0.4% today to 7.7% within three years, a material shift even as revenue is expected to fall by 7.1% yearly.

    • According to the analysts’ consensus narrative, the turnaround in profitability rests on strategic investments in recycling technology and a portfolio rebalancing toward lower-cost regions.

      • Management is targeting at least $1.1 billion in incremental cash flow by 2026 from these moves, potentially offsetting the drag from declining revenues.

      • However, consensus notes that there is considerable disagreement among analysts, with future earnings forecasts ranging from $1.3 billion to $2.8 billion, reflecting uncertainty about execution and market conditions.

    • The resurgence in forecast margins raises the question of whether cost improvements and growth in sustainable products can outpace ongoing industry headwinds. Analysts say success here will be crucial for the stock’s re-rating.

      • Bulls see proprietary recycling technology as a key differentiator that may unlock better pricing and margin gains versus peers.

      • Still, lagged investments or further market slowdowns would likely challenge this optimistic scenario, putting targets at risk.

    See what analysts expect if LYB executes on its margin turnaround. Dig into all sides of the story in the full consensus narrative. 📊 Read the full LyondellBasell Industries Consensus Narrative.

    • Despite ongoing losses, LyondellBasell has maintained its dividend, but filings reveal concerns about the sustainability of payouts given the company’s weak financial position.

    • Analysts’ consensus narrative flags that while incremental cash flow from cost-cutting and portfolio optimization is intended to support dividends even during downturns, heavy dependence on fossil-derived feedstocks and possible regulatory costs may put future payouts at risk.

      • Deferred capital projects and focus on conserving cash increase the threat that investments essential to future growth could be postponed as dividends are prioritized.

      • On the flip side, consensus suggests improved free cash flow generation from cost measures may buy the company more time to keep dividends steady, provided revenue pressures don’t accelerate.

    Continue Reading

  • is Novo Nordisk past its ‘peak uncertainty’?

    is Novo Nordisk past its ‘peak uncertainty’?

    At one point, it was Europe’s most valuable company.

    Now, as Danish pharmaceutical group Novo Nordisk prepares to publish its third-quarter earnings on Wednesday, the picture looks very different.

    Jonathan Raa | Nurphoto | Getty Images

    CNBC’s Charlotte Reed will travel to Copenhagen to speak with the company’s new CEO Mark Doustdar, a 30-year veteran of the company, who has been in the top job since August.

    It’s not been an easy ride so far, with the group announcing a sharp decline in sales, pressure on profit, a round of jobs cuts and continued competition from U.S. rivals when it comes to the blockbuster obesity drug market.

    Analysts’ views

    Despite this, Berenberg is positive on the stock, saying Novo has hit “peak uncertainty.”

    “Novo’s superior growth profile and best-in-class R&D returns warrants a higher valuation premium to its peers,” the bank added.

    Other analysts are less forgiving.

    Jefferies recently cut the stock’s rating to underperform, citing competitive pressure in the U.S. and pricing concerns. Meanwhile, UBS analysts are concerned Novo’s 8 billion Danish krone ($1.23 billion) one-off cost related to its restructuring has not been fully reflected on the bottom line, while adding that investors are continuing to question the group’s lack of consumer experience in the American market.

    On Oct. 17, U.S. President Donald Trump told a press conference that the price of Novo’s blockbuster weight-loss drug Ozempic would be “much lower” as part of the administration’s negotiations over pricing with the company.

    The share price has been under pressure since the start of the year.

    Stock Chart IconStock chart icon

    Tough year for Novo Nordisk shares

    Boardroom meltdown

    Earnings releases this week:

    Monday: Ryanair, Berkshire Hathaway

    Tuesday: BP, Philips, Ferrari, Uber, Pfizer

    Wednesday: Novo Nordisk, BMW, Orsted, ARM, McDonald’s

    Thursday: Astrazeneca, Commerzbank, Diageo, ArcelorMittal, AirBnB

    Friday: Daimler

    Continue Reading

  • Robin Hood review – Sean Bean gifts us the most gloriously bad TV offering of the year | Television

    Robin Hood review – Sean Bean gifts us the most gloriously bad TV offering of the year | Television

    Autumn is entering the home straight. Winter is coming. We are more than due, therefore, a piece of fantasy/folkloric tomfoolery set in the days of yore – which is further back than yesteryear and therefore more forgiving all round – stuffed…

    Continue Reading

  • Eurogamer Weekly Digest, 2nd November – highlights you might have missed this week in reviews, features, and news

    Eurogamer Weekly Digest, 2nd November – highlights you might have missed this week in reviews, features, and news

    Why, hello there! Perhaps you’re here for another helping of conveniently digestible reading material to peruse over your weekend cornflakes? In that case, pull up a chair and settle in as we head for darker corners. This…

    Continue Reading

  • Rosalía’s Berghain is a thundrous goth-pop hit – but is it opera? | Music

    Rosalía’s Berghain is a thundrous goth-pop hit – but is it opera? | Music

    The Top 10 of today’s Spotify Global Top 50 looks like business as usual: two Taylor Swift songs; Lady Gaga and Bruno Mars’ Die With a Smile hanging around for an eighth month; the eminently normal male pop stars Sombr and Alex Warren doing…

    Continue Reading

  • Govt committed to protect freedom of press: PM – RADIO PAKISTAN

    1. Govt committed to protect freedom of press: PM  RADIO PAKISTAN
    2. International Federation of Journalists slams growing crisis faced by journalists in Pakistan  Dawn
    3. Violations against Pak journos spike by 60pc over past year: Report  Tribune India

    Continue Reading

  • Ashby bodybuilder competes at Mr Olympia after transplant

    Ashby bodybuilder competes at Mr Olympia after transplant

    “As far as I am aware, I am the only person in the world to undergo a kidney transplant, and then become professional and then qualify for the Mr Olympia competition in America,” he said.

    “For the last few years I always felt like I could do it…

    Continue Reading

  • Flags raised in Doha as leaders gather for UN social development summit – UN News

    1. Flags raised in Doha as leaders gather for UN social development summit  UN News
    2. President Zardari to attend Second World Summit for Social Development in Doha  Geo TV
    3. President Paudel leaving for Qatar on November 3 – Public Service…

    Continue Reading

  • GAME RECAP: Oilers 3, Blackhawks 2 (OT)

    GAME RECAP: Oilers 3, Blackhawks 2 (OT)

    EDMONTON, AB – Evan Bouchard scored 2:43 into overtime, and Head Coach Kris Knoblauch earned his 100th career NHL victory on Saturday as the Edmonton Oilers came away with a 3-2 win over the Chicago Blackhawks to close out their three-game…

    Continue Reading